Search results
Jun 10, 2024 · David M. Goldenberg, MD, known for his pioneering work in monoclonal antibodies and immunotherapy, was awarded the Benedict Cassen Prize during the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting.
May 5, 2017 · Immunomedics President and CEO Cynthia L. Sullivan, and CSO and chief patent officer David M. Goldenberg, have resigned as company and Seattle Genetics end up-to-$2B collaboration.
He was the inventor and principal developer of the antibody-drug conjugate, Trodelvy®, approved by the FDA for the treatment of metastatic, recurrent triple-negative breast cancer in 2020, and for metastatic, recurrent urothelial cancer in 2021. He is the inventor of over 300 U.S. patents.
Since retiring from full-time research in 2017, Dr. Goldenberg has continued to publish scientific articles and to be an invited lecturer. Recently, he has turned to writing novels focused on medical research and espionage. He is currently working on sequels to The Scenturion Spy, his first book.
David M. Goldenberg, Sc.D., M.D., spent ~60 years in medical research, both clinical and nonclinical, in cancer research and autoimmune diseases.
Dr. David Goldenberg is a professor and the chair of the department of otolaryngology - head and neck surgery at Penn State in Hershey, Pennsylvania. Dr. Gopi Shah is a pediatric otolaryngologist and the co-host of BackTable ENT. Synopsis. First, Gopi and David review workup of thyroid nodules.
People also ask
Who is David Goldenberg?
What is Dr. Goldenberg currently working on?
Who is John Goldenberg?
Where does Mark Goldenberg currently live?
What did Adam Goldenberg do?
How many articles has Dr Goldenberg published?
Jul 10, 2005 · The 66-year-old Dr. Goldenberg founded the Center for Molecular Medicine and Immunology in 1983 -- when he was lured away from the University of Kentucky, where he had set up a cancer...
